Newsroom

PARIS--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: DNCA FINANCE (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. DNCA Invest...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of Illinois, captioned Siverd v. Camping World Holdings, Inc., et al., Case No. 1:26-cv-02710, on behalf of persons and entities that purchased or otherwise acquired Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE: CWH) securities between April 29, 2025 and February 24, 2026, inclusive...

PARIS--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: DNCA FINANCE (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. DNCA Invest...

PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today proudly announces that the CLIMB study (Confocal Laser Endomicroscopy as an IMaging Biomarker, ClinicalTrials.gov ID: NCT03492151) will be presented at the ASGE (American Society for Gastrointestinal Endoscopy) Presidential Plenary Session on Sunday, May 3, 2026, one of the mo...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments botaniques innovants pour le traitement des addictions, annonce aujourd’hui l’obtention d’un prêt de 500 000 euros octroyé par Bpifrance. Ce financement non dilutif, non anticipé, a vocation à soutenir la préparation de la soumission de la demande d’essai clinique de Phase 2 pour NFL-102, prévue mi-2026. NFL-102 est un candi...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addiction, today announces that it has secured a €500,000 loan granted by Bpifrance. This non-dilutive financing, which was not initially anticipated, is intended to support the preparation of the Phase 2 clinical trial application for NFL-102, expected in mid-2026. NFL-102 is a drug candidat...

ORGON, France--(BUSINESS WIRE)--Regulatory News: ID Logistics, (ISIN : FR0010929125, Mnémo : IDL) leader européen de la logistique contractuelle, annonce ses résultats de l’année 2025 avec un chiffre d’affaires en hausse de +14,2% à 3 737,0 M€ et un résultat opérationnel courant en progression de +11,8% à 165,2 M€. Eric HÉMAR, Président Directeur Général d’ID Logistics, commente : « ID Logistics a réalisé un exercice 2025 satisfaisant, confirmant la solidité de son modèle économique et l’engage...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article L.233-8 II of the French Commercial Code (Code de Commerce) and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (the French financial markets authority), Sopra Steria Group (Paris:SOP) hereby informs its shareholders that the number of shares and voting rights as at February 28, 2026, are: Total number of shares: 20,547,701 Theoretical number of voting rights: 26,585,574 Number of voting rights...

SAINT-JEAN-DE-SOUDAIN, France--(BUSINESS WIRE)--Regulatory News: SergeFerrari Group (FR00l 1950682 - SEFER), one of the world leaders in innovative composite materials, listed on Euronext Paris – compartment C, today announced its consolidated full-year results as of December 31, 2025, approved by the Supervisory Board at its meeting on March 11, 2026. These consolidated financial statements have been audited by the Statutory Auditors, whose report is currently being prepared. Sébastien Baril,...

ORGON, France--(BUSINESS WIRE)--Regulatory News: ID Logistics, (ISIN: FR0010929125, Mnemo: IDL) European leader in contract logistics, announces its results for 2025, with revenues up +14.2% to €3,737.0 million and underlying operating income up +11.8% to €165.2 million. Eric HÉMAR, Chairman and CEO of ID Logistics, comments: "ID Logistics had a satisfactory 2025 financial year, confirming the strength of its business model and the ongoing commitment of its teams. The improvement in results in...